Published in Hepatitis Weekly, July 22nd, 2002
The Danish subsidiary will assist Plexus in developing new vaccines based on a combination of advanced computational and experimental biochemical methods.
Through a license agreement with the Danish scientists Professor Soeren Brunak and Professor Soeren Buus, Plexus has secured exclusive access to technology that will constitute a cornerstone in the activities of Plexus Denmark and significantly strengthen the overall...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly